Zenith Capital Corp Ordinary Shares ZHCLF
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.30
- Bid/Ask
- $0.00 / $0.40
- Shares Outstanding
- 161.02M
- Market Cap
- $255,570.92
- Volume/Avg
- 250 / 18,392
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary, which is a clinical-stage biotechnology company focused on discovering and developing bromodomain (BET) inhibitors for the treatment of cancer and other disorders with unmet medical need. It is a epigenetic platform of biology and chemistry has generated differentiated, potent and selective BET inhibitors. Its goal is to be a epigenetic company translating bromodomain biology into impactful therapies. Its programs involve NUT Carcinoma, Prostate Cancer, MPNST, Colorectal Cancer, Ovarian Cancer, Lung Cancer, MYC-Driven Cancers, and Breast Cancer.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
|
Metric
|
ZHCLF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ZHCLF
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
ZHCLF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|$Mv^!T! | LOCK|!S^l | $126B | |||
| Moderna Inc
MRNA
| LOCK|Hq!$L^h | LOCK|N?< | $90B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|Cgfb#M | LOCK|V&KJX | $80B | |||
| argenx SE ADR
ARGX
| LOCK|w<?nJx | LOCK|L& | $53B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|#P?>>M! | LOCK|dzN | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|@J^fplP | LOCK|Ds%Ym | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|#F?X!p!% | LOCK|mCP^ | $26B | |||
| Incyte Corp
INCY
| LOCK|SM&P?MT | LOCK|#L# | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|Y@@>!>N | LOCK|qj@ | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|%wWd$fp | LOCK|^gl | $14B |
United States